About Innovassynth Technologies
Innovassynth Technologies is a company based in Mumbai (India) founded in 1964. The company has 293 employees as of April 06, 2025. Innovassynth Technologies offers products and services including Nucleosides, Specialty Chemicals, and Contract Manufacturing. Innovassynth Technologies operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
- Headquarter Mumbai, India
- Employees 293 as on 06 Apr, 2025
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Innovassynth Technologies (India ) Limited
- Date of Incorporation 04 Dec, 2001
- Jurisdiction Khopoli, Maharashtra, India
-
Annual Revenue
$18.85 M (USD)-20.8as on Mar 31, 2024
-
Net Profit
-$54.66 K (USD)83.84as on Mar 31, 2024
-
EBITDA
$1.31 M (USD)212.68as on Mar 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
293
as on Apr 06, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Innovassynth Technologies
Innovassynth Technologies offers a comprehensive portfolio of products and services, including Nucleosides, Specialty Chemicals, and Contract Manufacturing.
Products for nucleic acid chemistry and manufacturing services
Custom development of organometallics and polymers additives
Full-scale manufacturing for pharma and chemical intermediates
People of Innovassynth Technologies
Unlock access to complete
Unlock access to complete
Funding Insights of Innovassynth Technologies
Detailed funding history for Innovassynth Technologies
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Innovassynth Technologies
Investment portfolio details for Innovassynth Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Innovassynth Technologies
Detailed financials for Innovassynth Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Innovassynth Technologies Comparisons
Peer comparison for Innovassynth Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Innovassynth Technologies
Innovassynth Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| Locked | Locked | Locked |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| Locked | Locked | Locked |
APIs and enzymes are manufactured through fermentation by the CDMO.
|
|
| Locked | Locked | Locked |
APIs and finished products are developed and manufactured.
|
|
| Locked | Locked | Locked |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| Locked | Locked | Locked |
APIs and peptides are developed and manufactured by Asymchem.
|
Detailed competitors of Innovassynth Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Innovassynth Technologies
Complete news archive for Innovassynth Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Innovassynth Technologies
Innovassynth Technologies was founded in 1964.
Innovassynth Technologies is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
As of Apr 06, 2025, the latest employee count at Innovassynth Technologies is 293.
Annual revenue of Innovassynth Technologies is $18.85M as on Mar 31, 2024.
Innovassynth Technologies (formerly known as Chemicals Division of Indian Organic Chemicals) is engaged in contract research, custom synthesis and contract manufacturing. Business segments include Pharma intermediates, protected nucleosides and amidites, protected amino acids for peptide synthesis, fine chemicals and nutraceuticals. It has also set up a cGMP pilot plant facility where 10-15 Kg batch size production is possible and is going for US FDA approval in near future. The company claims to have more than 45 customers in USA, Europe and Japan for its contract manufacturing business.
Innovassynth Technologies's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.
Innovassynth Technologies offers Nucleosides, Specialty Chemicals, and Contract Manufacturing.